MX2020011016A - Composiciones para el tratamiento de condiciones de la piel. - Google Patents

Composiciones para el tratamiento de condiciones de la piel.

Info

Publication number
MX2020011016A
MX2020011016A MX2020011016A MX2020011016A MX2020011016A MX 2020011016 A MX2020011016 A MX 2020011016A MX 2020011016 A MX2020011016 A MX 2020011016A MX 2020011016 A MX2020011016 A MX 2020011016A MX 2020011016 A MX2020011016 A MX 2020011016A
Authority
MX
Mexico
Prior art keywords
compositions
skin conditions
treatment
conditions associated
dysbiosis
Prior art date
Application number
MX2020011016A
Other languages
English (en)
Inventor
Paul Wagner
Original Assignee
Forte Subsidiary Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Forte Subsidiary Inc filed Critical Forte Subsidiary Inc
Publication of MX2020011016A publication Critical patent/MX2020011016A/es

Links

Classifications

    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/06—Antipsoriatics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/66—Microorganisms or materials therefrom
    • A61K35/74—Bacteria
    • A61K35/741—Probiotics
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K47/00—Medicinal preparations characterised by the non-active ingredients used, e.g. carriers or inert additives; Targeting or modifying agents chemically bound to the active ingredient
    • A61K47/06—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite
    • A61K47/08—Organic compounds, e.g. natural or synthetic hydrocarbons, polyolefins, mineral oil, petrolatum or ozokerite containing oxygen, e.g. ethers, acetals, ketones, quinones, aldehydes, peroxides
    • A61K47/10—Alcohols; Phenols; Salts thereof, e.g. glycerol; Polyethylene glycols [PEG]; Poloxamers; PEG/POE alkyl ethers
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0014—Skin, i.e. galenical aspects of topical compositions
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0031—Rectum, anus
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K9/00—Medicinal preparations characterised by special physical form
    • A61K9/0012—Galenical forms characterised by the site of application
    • A61K9/0053—Mouth and digestive tract, i.e. intraoral and peroral administration
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P17/00—Drugs for dermatological disorders
    • A61P17/10—Anti-acne agents
    • C—CHEMISTRY; METALLURGY
    • C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12N—MICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N1/00—Microorganisms, e.g. protozoa; Compositions thereof; Processes of propagating, maintaining or preserving microorganisms or compositions thereof; Processes of preparing or isolating a composition containing a microorganism; Culture media therefor
    • C12N1/20—Bacteria; Culture media therefor
    • A—HUMAN NECESSITIES
    • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00—Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K2035/11—Medicinal preparations comprising living procariotic cells

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Medicinal Chemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Animal Behavior & Ethology (AREA)
  • Public Health (AREA)
  • Veterinary Medicine (AREA)
  • Epidemiology (AREA)
  • Engineering & Computer Science (AREA)
  • Dermatology (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Organic Chemistry (AREA)
  • Microbiology (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Mycology (AREA)
  • Molecular Biology (AREA)
  • Oil, Petroleum & Natural Gas (AREA)
  • Genetics & Genomics (AREA)
  • Biotechnology (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Virology (AREA)
  • Biomedical Technology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biochemistry (AREA)
  • General Engineering & Computer Science (AREA)
  • Nutrition Science (AREA)
  • Physiology (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)

Abstract

En el presente documento se describen métodos y composiciones para el tratamiento de afecciones cutáneas asociadas con la disbiosis. Las afecciones de la piel asociadas con la disbiosis para el tratamiento usando composiciones y métodos descritos en este documento incluyen dermatitis atópica, eccema, dermatitis, psoriasis, rosácea y acné. Las composiciones incluyen una sola o más de una cepa de bacterias derivadas de donantes sanos para su administración para proporcionar terapia para afecciones de la piel asociadas con microbiota desregulada. Tales composiciones incluyen bacterias gram negativas y/o gram positivas.
MX2020011016A 2018-04-18 2019-04-17 Composiciones para el tratamiento de condiciones de la piel. MX2020011016A (es)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201862659566P 2018-04-18 2018-04-18
US201862703742P 2018-07-26 2018-07-26
PCT/US2019/027912 WO2019204475A1 (en) 2018-04-18 2019-04-17 Compositions for the treatment of skin conditions

Publications (1)

Publication Number Publication Date
MX2020011016A true MX2020011016A (es) 2021-01-29

Family

ID=68236163

Family Applications (1)

Application Number Title Priority Date Filing Date
MX2020011016A MX2020011016A (es) 2018-04-18 2019-04-17 Composiciones para el tratamiento de condiciones de la piel.

Country Status (13)

Country Link
US (3) US20190321416A1 (es)
EP (1) EP3784260A4 (es)
JP (1) JP2021522323A (es)
KR (1) KR20210011926A (es)
CN (1) CN112512540A (es)
BR (1) BR112020021274A2 (es)
CA (1) CA3097607A1 (es)
CL (1) CL2020002679A1 (es)
GB (1) GB2589729A (es)
MX (1) MX2020011016A (es)
SG (1) SG11202010294RA (es)
WO (1) WO2019204475A1 (es)
ZA (1) ZA202006610B (es)

Families Citing this family (11)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US10293005B2 (en) 2016-04-19 2019-05-21 The United States Of America, As Represented By The Secretary, Department Of Health And Human Services Use of gram negative species to treat atopic dermatitis
JP2019513769A (ja) 2016-04-19 2019-05-30 ザ ユナイテッド ステイツ オブ アメリカ，アズ レプリゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ アトピー性皮膚炎を処置するためのグラム陰性種の使用
WO2021138599A1 (en) * 2020-01-03 2021-07-08 Forte Subsidiary, Inc. Cosmetic compositions
WO2021146598A1 (en) * 2020-01-17 2021-07-22 Second Genome, Inc. Methods and compositions for treating atopic dermatitis
KR102558085B1 (ko) * 2021-09-08 2023-07-24 코스맥스 주식회사 비피도박테리움 애니멀리스 서브스페시스 락티스 균주 및 그의 피부 상태 개선 용도
EP4183403A1 (en) 2021-11-19 2023-05-24 Lietuvos Sveikatos Mokslu Universitetas Modification of fecal microbiota with capsules containing gram-positive bacteria
KR102691627B1 (ko) * 2022-04-19 2024-08-06 코스맥스 주식회사 로제오모나스 뮤코사 균주 및 그의 피부 상태 개선 용도
CN115140846B (zh) * 2022-07-06 2024-06-21 江苏聚庚科技股份有限公司 一种复合处理剂、制备方法及其在净化废水中的应用
CN116333923A (zh) * 2023-02-21 2023-06-27 上海市第一人民医院 一种人葡萄球菌SHoFu616菌株、其筛选方法和用于制备预防和治疗特应性皮炎药物的应用
WO2024188195A1 (zh) * 2023-03-10 2024-09-19 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 一种粘液玫瑰单胞菌、菌剂和胞外多糖及其制备方法和应用
CN116407565B (zh) * 2023-03-15 2023-10-31 中国医学科学院皮肤病医院(中国医学科学院皮肤病研究所) 一种粘液玫瑰单胞菌活菌制剂及其胞外多糖在制备用于治疗银屑病的药物中的应用

Family Cites Families (6)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
CN105534978A (zh) * 2009-06-30 2016-05-04 德安生医有限公司 用于治疗红斑痤疮或红脸相关皮肤病的含黄连素或其类似物的组合物
US20120076738A1 (en) * 2010-09-28 2012-03-29 Michael Graeber Combination treatment for dermatological conditions
ES2853327T3 (es) * 2013-07-11 2021-09-15 Micreos Human Health Bv Tratamiento combinado para la dermatitis atópica
MA41020A (fr) * 2014-11-25 2017-10-03 Evelo Biosciences Inc Compositions probiotiques et prébiotiques, et leurs procédés d'utilisation pour la modulation du microbiome
WO2016172196A1 (en) * 2015-04-20 2016-10-27 Pätzold Bernhard Methods and compositions for changing the composition of the skin microbiome using complex mixtures of bacterial strains
JP2019513769A (ja) * 2016-04-19 2019-05-30 ザ ユナイテッド ステイツ オブ アメリカ，アズ レプリゼンテッド バイ ザ セクレタリー，デパートメント オブ ヘルス アンド ヒューマン サービシーズ アトピー性皮膚炎を処置するためのグラム陰性種の使用

Also Published As

Publication number Publication date
EP3784260A1 (en) 2021-03-03
BR112020021274A2 (pt) 2021-04-13
US20210228650A1 (en) 2021-07-29
GB2589729A (en) 2021-06-09
US20210236562A1 (en) 2021-08-05
GB202017321D0 (en) 2020-12-16
US20190321416A1 (en) 2019-10-24
CN112512540A (zh) 2021-03-16
ZA202006610B (en) 2022-08-31
WO2019204475A1 (en) 2019-10-24
CL2020002679A1 (es) 2021-04-30
EP3784260A4 (en) 2022-03-09
CA3097607A1 (en) 2019-10-24
JP2021522323A (ja) 2021-08-30
SG11202010294RA (en) 2020-11-27
KR20210011926A (ko) 2021-02-02

Similar Documents

Publication Publication Date Title
MX2020011016A (es) Composiciones para el tratamiento de condiciones de la piel.
MX2022001607A (es) Composiciones y metodos para tratar la psoriasis y la dermatitis atopica usando prevotella histicola.
WO2017136795A8 (en) Bacteria engineered to treat diseases associated with tryptophan metabolism
WO2019094642A8 (en) T cell manufacturing compositions and methods
WO2019099682A9 (en) Compositions and methods for treating immune disorders using immune modulating lactococcus bacteria strains
MX2020012018A (es) Composiciones para el tratamiento de condiciones de la piel.
MX2021006581A (es) Bacterias modificadas para tratar enfermedades asociadas con hiperamonemia.
PH12017500680A1 (en) Compositions and methods of use for treating metabolic disorders
BR112016028964A2 (pt) métodos de tratamento com antagonistas contra pd-1 e pd-l1 em combinação com terapia de radiação
GB2535666A (en) Antimicrobial compositions
MX2021016034A (es) Composiciones y métodos de tratamiento de una afección mediada por th2 usando prevotella.
PE20150223A1 (es) Anticuerpos antagonistas mejorados contra factor-8 de crecimiento y diferenciacion y usos de los mismos
MX2019009132A (es) Composiciones bacterianas sinergicas y sus metodos de produccion y usos.
WO2016210384A3 (en) Bacteria engineered to treat metabolic diseases
BR112016019432A8 (pt) composição terapêutica, kit e seus usos na terapia gênica contra degeneração da retina
EP4338804A3 (en) Epinephrine spray formulations
WO2017139697A8 (en) Bacteria engineered to treat diseases associated with hyperammonemia
PH12017501993A1 (en) Methods of treating epstein-barr-virus-associated lymphoproliferative disorders by t cell therapy
PH12017501300A1 (en) Novel iodophor composition and methods of use
ZA202203603B (en) Mitoriboscins: mitochondrial-based therapeutics targeting cancer cells, bacteria, and pathogenic yeast
AU2018337668A1 (en) Improved supraparticles
AU2018271862A1 (en) Combination therapy
PH12019501439B1 (en) Use of lactic acid bacteria to treat or prevent gestational diabetes mellitus
WO2020049552A9 (en) Tissue repair by activated cells
EP4467131A3 (en) Microbiota restoration therapy (mrt) compositions and methods of manufacture